Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Del Prato

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
Diabetes Technology & Therapeutics|January 5, 2005
Targeting insulin resistance and beta-cell dysfunction: the role of thiazolidinedionesS Del Prato, P Marchetti
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 19, 2005
Beta- and alpha-cell dysfunction in type 2 diabetesS Del Prato, P Marchetti
Journal of Diabetes and Its Complications|September 1, 1996
Insulin resistance and diabetes mellitusR A DeFronzo, S Del Prato
Diabetes, Nutrition & Metabolism|April 8, 2003
Sulfonylureas and hypoglycaemiaS Del Prato, M Aragona, A Coppelli
Diabetologia|May 17, 2012
Regulation of medical devices used in diabetology in Europe: time for reform?A J M Boulton, S Del Prato
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 24, 2016
Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injuryG Penno, M Garofolo, S Del Prato
International Journal of Clinical Practice. Supplement|December 6, 2007
We have the evidence, we need to act to improve diabetes careS Del Prato, E Horton, R Nesto, et al.
Acta Diabetologica|April 12, 2003
Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patientsS Del Prato, D W Erkelens, M Leutenegger
Diabetes, Obesity & Metabolism|November 9, 2013
Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylureaV Lukashevich, S Del Prato, M Araga, et al.
Diabetes & Metabolism|September 23, 2003
Reducing insulin resistance with metformin: the evidence todayR Giannarelli, M Aragona, A Coppelli, et al.
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
Diabetes Technology & Therapeutics|January 5, 2005
Targeting insulin resistance and beta-cell dysfunction: the role of thiazolidinedionesS Del Prato, P Marchetti
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 19, 2005
Beta- and alpha-cell dysfunction in type 2 diabetesS Del Prato, P Marchetti
Journal of Diabetes and Its Complications|September 1, 1996
Insulin resistance and diabetes mellitusR A DeFronzo, S Del Prato
Diabetes, Nutrition & Metabolism|April 8, 2003
Sulfonylureas and hypoglycaemiaS Del Prato, M Aragona, A Coppelli
Diabetologia|May 17, 2012
Regulation of medical devices used in diabetology in Europe: time for reform?A J M Boulton, S Del Prato
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 24, 2016
Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injuryG Penno, M Garofolo, S Del Prato
International Journal of Clinical Practice. Supplement|December 6, 2007
We have the evidence, we need to act to improve diabetes careS Del Prato, E Horton, R Nesto, et al.
Acta Diabetologica|April 12, 2003
Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patientsS Del Prato, D W Erkelens, M Leutenegger
Diabetes, Obesity & Metabolism|November 9, 2013
Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylureaV Lukashevich, S Del Prato, M Araga, et al.
Diabetes & Metabolism|September 23, 2003
Reducing insulin resistance with metformin: the evidence todayR Giannarelli, M Aragona, A Coppelli, et al.
Pageof 21